Question 1
Cause of GI Problems
Diagnosing lactase non-persistence from the biopsy data, ruling out other causes, and understanding the pathophysiology of her symptoms.
Diagnosis
Primary lactase non-persistence (adult-type hypolactasia) — a selective, isolated deficiency of the brush border enzyme lactase-phlorizin hydrolase, causing inability to hydrolyze lactose. All other brush border enzymes are within normal range. The small bowel biopsy is histologically normal. Symptoms are triggered exclusively by dairy ingestion.
Biopsy enzyme activity — the data tells the story
The brush border enzyme panel is the key diagnostic evidence. Four enzymes measured; only one is abnormal:
MaltaseNormal ✓
SucraseNormal ✓
IsomaltaseNormal ✓
LactaseSEVERELY DEFICIENT ✗
The isolation of the deficiency is diagnostically critical. If all enzymes were reduced, this would suggest diffuse mucosal damage (celiac disease, Crohn's, infectious enteritis). The fact that only lactase is affected — while maltase, sucrase, and isomaltase are all essentially normal — confirms a selective enzyme deficiency, not structural intestinal pathology.
Why does low lactase cause these specific symptoms?
- 1Lactose not cleaved: Without lactase, lactose (glucose + galactose, β-1,4 bond) passes intact from the small intestine into the colon. No other brush border enzyme can cleave β-1,4 bonds.
- 2Osmotic diarrhea: Unabsorbed lactose is an osmotically active solute. It draws water into the colonic lumen → watery diarrhea. This is the direct osmotic mechanism.
- 3Bacterial fermentation: Colonic bacteria ferment lactose → short-chain fatty acids (butyrate, propionate, acetate) + CO₂ + H₂ gas. Gas production → bloating, cramping, gurgling (borborygmi).
- 4Acidic stool: Fermentation products lower colonic pH → can cause perianal irritation. Stool pH <5.5 is a clinical clue to carbohydrate malabsorption.
- 5Positive hydrogen breath test: H₂ produced by bacterial fermentation is absorbed into blood and exhaled → elevated breath H₂ after lactose challenge is the standard non-invasive diagnostic test.
Ruling out alternative diagnoses
- 1Celiac disease excluded: Normal small bowel biopsy — celiac causes villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis on biopsy. All brush border enzymes would be reduced (diffuse mucosal damage), not just lactase.
- 2Crohn's disease excluded: No history of abdominal surgery, no pathologic changes on biopsy. Crohn's causes transmural inflammation, skip lesions, granulomas.
- 3IBS re-evaluated: The prior IBS diagnosis was likely incorrect — or at minimum incomplete. IBS is a functional diagnosis (no structural or enzymatic cause), but her enzyme data reveals a clear biochemical explanation. Dairy-specific symptom triggers and the hydrogen breath test pattern are not typical of IBS.
- 4Sucrase-isomaltase deficiency excluded: Sucrase 77 and isomaltase 83 are both within normal range. This condition would cause symptoms from starch and sucrose ingestion, not specifically dairy.
Primary vs. secondary lactase deficiency
| Type | Mechanism | Biopsy | Onset | Reversibility |
|---|---|---|---|---|
| Primary (this patient's type) | Genetically programmed downregulation of LCT gene after weaning. Normal developmental process in most of the world's population. | Histologically normal — selective loss of lactase expression only. | Late childhood to early adulthood. Gradual onset over years. | Not reversible — permanent loss of lactase persistence. Managed with dietary modification and lactase supplements. |
| Secondary | Temporary loss from mucosal damage (gastroenteritis, celiac, Crohn's, radiation). Lactase is the most vulnerable brush border enzyme. | Shows underlying pathology (villous blunting, inflammation, etc.) | Acute, follows illness or treatment. | Reversible once underlying cause treated and mucosa heals. |
| Congenital (rare) | Autosomal recessive. Complete absence of lactase from birth. Presents with severe diarrhea from first breast milk feeding. | Normal histology. | From birth — immediate onset with first feeding. | Permanent. Life-long lactose-free diet required. |
Question 2
How Glucose and Galactose Move from Lumen to Blood
The complete transport pathway — apical uptake, intracellular handling, basolateral exit, and portal delivery.
Step 1 — Lactose hydrolysis (the missing step)
Lactose (lumen)
→
Lactase-phlorizin hydrolase
→
Glucose + Galactose
→
Ready for absorption
Lactase-phlorizin hydrolase is a single integral membrane protein anchored in the brush border with two catalytic sites: one cleaves lactose (β-galactosidase activity), the other cleaves phlorizin and other glycolipids (phlorizin hydrolase activity). The enzyme is expressed exclusively in the small intestinal brush border. The patient's lactase activity of 2 (vs. normal 44) means this step essentially doesn't happen — lactose passes to the colon intact.
Step 2 — Apical membrane uptake via SGLT1
SGLT1 (Sodium-Glucose Linked Transporter 1, SLC5A1) is the sole apical transporter for both glucose and galactose. This is a secondary active transporter:
- 1Cotransport stoichiometry: 2 Na⁺ ions are cotransported with every 1 glucose or galactose molecule. Both Na⁺ and the sugar must bind before the transporter can cycle.
- 2Driving force: The low intracellular Na⁺ maintained by basolateral Na⁺/K⁺-ATPase creates the electrochemical gradient that drives Na⁺ (and therefore glucose/galactose) into the cell — even against the glucose concentration gradient.
- 3Energy source: ATP is consumed indirectly — by Na⁺/K⁺-ATPase to maintain the Na⁺ gradient. SGLT1 itself uses no ATP but is ultimately dependent on this gradient. Hence "secondary" active transport.
- 4Location: Expressed throughout the small intestine, with highest density in the proximal jejunum. Expression in the duodenum is lower. Also expressed in kidney proximal tubule (renal glucose reabsorption — the target of SGLT2 inhibitor drugs).
Why galactose uses SGLT1 too: SGLT1 has structural affinity for both D-glucose and D-galactose (stereoisomers differing only at the C-4 position). Fructose, by contrast, cannot use SGLT1 — it uses the separate GLUT5 transporter. This is why glucose-galactose malabsorption (rare congenital SGLT1 mutation) spares fructose absorption.
Clinical relevance — ORT: SGLT1's sodium cotransport is the basis of oral rehydration therapy. Adding glucose to electrolyte solution activates SGLT1 → drives Na⁺ absorption → water follows osmotically. Even maximal CFTR-mediated secretion (cholera) cannot overcome SGLT1-mediated absorption with adequate glucose present.
Glucose-galactose malabsorption: Rare autosomal recessive mutation in SGLT1 → neither glucose nor galactose absorbed → life-threatening osmotic diarrhea from birth that stops completely with a fructose-only diet. Dramatic illustration of SGLT1's indispensability.
Steps 3 & 4 — Intracellular transit and basolateral exit via GLUT2
Once inside the enterocyte, glucose and galactose move toward the basolateral membrane. Neither undergoes significant metabolism within the enterocyte (unlike fructose, some of which is converted to glucose).
GLUT2 (SLC2A2) on the basolateral membrane mediates exit:
- 1Facilitated diffusion: GLUT2 requires no energy and no Na⁺ — it moves monosaccharides down their concentration gradient. As long as intracellular glucose/galactose exceeds portal blood concentration, exit is passive and continuous.
- 2Low affinity, high capacity: GLUT2 has low affinity (high Km ~17 mM) but very high maximum transport rate. It is designed to handle large post-meal glucose surges without saturating.
- 3Also transports fructose: GLUT2 is non-selective — it transports glucose, galactose, and fructose equally. This is why all three monosaccharides use the same exit route despite entering via different apical transporters.
GLUT2 apical recruitment: At very high luminal glucose concentrations, GLUT2 can be rapidly inserted into the apical membrane as a high-capacity overflow absorption route alongside SGLT1. This may account for significant additional glucose absorption after large carbohydrate meals.
Galactose — hepatic fate: After GLUT2 exit into portal blood, galactose travels to the liver where it is almost completely extracted on first pass. Hepatic galactokinase phosphorylates it to galactose-1-phosphate → UDP-galactose → incorporated into glycogen or glycoproteins. Very little galactose reaches systemic circulation normally. This is why galactosemia (deficiency of galactose-1-phosphate uridylyltransferase) causes hepatic accumulation and liver damage.
Complete transport summary — lumen to blood
Lactose (lumen)
→
Lactase → Glc + Gal
→
SGLT1 (apical, Na⁺-coupled)
→
Enterocyte cytoplasm
→
GLUT2 (basolateral, facilitated)
→
Portal vein → Liver
Energy accounting: The entire process uses ATP only via basolateral Na⁺/K⁺-ATPase. SGLT1 rides the Na⁺ gradient created by that pump. GLUT2 is passive. The enterocyte invests ATP to keep intracellular Na⁺ low — this powers glucose and galactose absorption indirectly.
Question 3
Primary Carbohydrate Sources & Their Digesting Enzymes
What carbohydrates are in the diet, where they come from, and which brush border oligosaccharidases handle each one.
The three major dietary carbohydrate sources
Starch (~60% of carbohydrate intake)
The dominant dietary carbohydrate. A glucose polymer found in grains (wheat, rice, corn), legumes, root vegetables (potatoes). Two forms: amylose (linear, α-1,4 bonds only, ~20%) and amylopectin (branched, α-1,4 backbone + α-1,6 at branch points every 24–30 glucose units, ~80%). The α-1,6 branch points require specific enzymatic action.
Lactose (dairy — the problem here)
A disaccharide of glucose + galactose linked by a β-1,4 bond. Found exclusively in mammalian milk and dairy products (milk, yogurt, cheese, ice cream, butter). The β-1,4 bond is unusual — no amylase can cleave it. It requires the specific β-galactosidase activity of lactase-phlorizin hydrolase. This enzyme is the only brush border carbohydrase that handles β linkages.
Sucrose (table sugar)
A disaccharide of glucose + fructose linked by an α-1,2 bond (between the anomeric carbons of both sugars). Found in cane sugar, beet sugar, fruits, and processed foods. The α-1,2 bond is specifically cleaved by the sucrase domain of the sucrase-isomaltase complex. Sucrase activity is normal (77 vs. 87), so sucrose is handled without difficulty.
The brush border oligosaccharidases — locations, substrates, products
After luminal digestion by salivary and pancreatic amylases reduces starch to oligosaccharides, the brush border enzymes complete the final hydrolysis to monosaccharides. These are integral membrane proteins with their active sites facing the intestinal lumen, expressed throughout the duodenum and jejunum (highest density in proximal jejunum):
| Enzyme | Patient (Normal) | Bond cleaved | Substrate | Products | Significance |
|---|---|---|---|---|---|
| Maltase-glucoamylase | 234 (266) — Normal | α-1,4 (terminal) | Maltose, maltotriose, short linear oligosaccharides from amylase digestion | Glucose + Glucose | Primary enzyme for final starch digestion products. Glucoamylase domain can also processively cleave single glucose units from the non-reducing end of longer chains. |
| Sucrase-isomaltase complex (bifunctional single protein) |
Sucrase: 77 (87) Isomaltase: 83 (97) — Both Normal |
Sucrase: α-1,2 Isomaltase: α-1,6 |
Sucrase: sucrose Isomaltase: α-limit dextrins (the branch-point-containing oligosaccharides left after amylase action) |
Sucrase: Glucose + Fructose Isomaltase: Glucose units |
Most abundant brush border carbohydrase. Critical for completing starch digestion — without isomaltase, α-limit dextrins would accumulate. Congenital deficiency = symptoms from both starch and sucrose. |
| Lactase-phlorizin hydrolase | 2 (44) — SEVERELY DEFICIENT | β-1,4 | Lactose (the only dietary disaccharide with a β-1,4 bond) | Glucose + Galactose | The ONLY brush border enzyme handling β-glucosidic bonds. Lowest basal expression of all disaccharidases. Most sensitive to mucosal damage. The 95% reduction = essentially zero functional lactase. |
| Trehalase | Not measured | α-1,1 (trehalose) | Trehalose (found in mushrooms, insects, some yeasts) | Glucose + Glucose | Narrow substrate specificity. Deficiency causes diarrhea after mushroom ingestion — rare clinical scenario but board-testable. |
Key pattern from the biopsy data: Maltase, sucrase, and isomaltase are all ~86–89% of normal — essentially intact. Lactase alone is 5% of normal. This pattern can only result from a selective reduction in LCT gene expression, not from diffuse mucosal damage. It is the biochemical fingerprint of primary lactase non-persistence.
Starch digestion pathway — from food to monosaccharides
- 1Salivary α-amylase (mouth/stomach): Cleaves internal α-1,4 bonds → maltose, maltotriose, α-limit dextrins. Cannot cleave α-1,6 branch points or terminal bonds. Active until denatured by gastric acid (~pH 3).
- 2Pancreatic α-amylase (duodenum): Identical specificity to salivary amylase but secreted in far greater quantity. Dominates starch digestion. Activated by HCO₃⁻ environment. Reduces starch to a mixture of maltose, maltotriose, and α-limit dextrins.
- 3Maltase (brush border): Cleaves maltose → 2 glucose; maltotriose → glucose + maltose. Also processively cleaves longer linear chains.
- 4Isomaltase (brush border): Specifically cleaves the α-1,6 branch point bonds in α-limit dextrins, releasing the branched glucose units that amylase cannot access.
- 5Final product: 100% free glucose, absorbed via SGLT1. Starch digestion requires the sequential action of luminal amylases (endo-) followed by brush border exoglycosidases. No single enzyme accomplishes complete digestion.
Question 4
Is the Time of Onset Significant?
Why primary lactase non-persistence characteristically develops in late childhood to early adulthood — and what this tells us about the underlying mechanism.
The onset timing is highly significant — it is a diagnostic clue
The patient is 18 years old with symptoms worsening over the past year. This gradual onset in late adolescence is entirely characteristic of primary lactase non-persistence. The timing reflects the developmental biology of LCT gene regulation. If symptoms had been present from birth, congenital lactase deficiency would be suspected. If they developed acutely after a GI illness, secondary lactase deficiency would be suspected.
The developmental biology of lactase expression
- 1Fetal/neonatal life: Lactase expression is high from ~26 weeks gestation onward. This is essential — breast milk is the sole caloric source for infants, and lactose is its primary carbohydrate (~7g/100mL). Every mammal (including all humans) is born with high lactase activity.
- 2After weaning — the divergence: In most mammals and in ~65% of the global human population, lactase expression begins declining after weaning. This decline is genetically programmed — controlled by regulatory variants upstream of the LCT gene. It is the ancestral, normal mammalian condition. Lactase persistence is the derived (mutant) state.
- 3Timeline of decline: In people with lactase non-persistence, the decline is gradual. It typically begins in childhood (ages 2–5) and continues through adolescence. By the late teens to early twenties, lactase activity has fallen to its permanently low adult level. At 18, this is exactly the right age for these symptoms to be becoming clinically apparent.
- 4Gradual symptom onset: Because the decline in lactase activity is slow, symptoms develop gradually over years rather than acutely. This also explains why the prior IBS diagnosis was plausible — the symptoms resembled functional bowel disorder and worsened gradually without an obvious precipitating event.
The genetics of lactase persistence
Lactase persistence (continued high lactase expression into adulthood) is caused by single nucleotide polymorphisms (SNPs) in a regulatory region ~14 kb upstream of the LCT gene — not in the coding sequence itself, but in an enhancer element that controls transcription.
Key SNPs:
C/T-13910 (rs4988235) — European populations. The T allele maintains lactase expression. This mutation arose ~10,000 years ago in Northern Europe, coinciding with the emergence of cattle domestication and dairying.
G/A-13915, C/G-13907, T/G-13915 — Independent mutations in African and Middle Eastern pastoralist populations. Convergent evolution — lactase persistence evolved independently multiple times in dairying cultures.
C/T-13910 (rs4988235) — European populations. The T allele maintains lactase expression. This mutation arose ~10,000 years ago in Northern Europe, coinciding with the emergence of cattle domestication and dairying.
G/A-13915, C/G-13907, T/G-13915 — Independent mutations in African and Middle Eastern pastoralist populations. Convergent evolution — lactase persistence evolved independently multiple times in dairying cultures.
Evolutionary significance: Lactase persistence is one of the strongest signals of positive selection in the human genome — in populations that domesticated cattle, individuals who could digest milk as adults had a significant caloric advantage, especially during famines. This selective pressure drove lactase persistence alleles to high frequency (~90% in Northern Europeans, ~80% in Scandinavians) over ~400 generations.
Global prevalence of lactase non-persistence: ~65% of adult humans worldwide cannot fully digest lactose. Highest rates: East Asian (~90%), West African (~75%), Southern European (~50%). Lowest rates: Northern European (~5-15%), nomadic East African pastoralists (~15%). The patient's ethnicity is not specified, but primary lactase non-persistence is the most common carbohydrate enzyme deficiency globally.
Onset timing distinguishes the three types of lactase deficiency
| Type | Onset | Age | Biopsy | Genetic basis |
|---|---|---|---|---|
| Primary (non-persistence) | Gradual, insidious over months to years | Late childhood → young adulthood (18 yo) | Histologically normal. Selective lactase reduction only. | Autosomal, regulatory SNPs upstream of LCT gene. LCT coding sequence normal. |
| Secondary | Acute, follows mucosal insult | Any age — after gastroenteritis, celiac diagnosis, etc. | Shows underlying pathology. All enzymes reduced. | Not inherited — acquired. Reversible with mucosal healing. |
| Congenital | From first feed — immediate | Birth | Normal histology. Selective lactase absence. | Autosomal recessive. Mutation in LCT coding sequence. Extremely rare. |
Question 5
What Did the Physician Recommend?
The full clinical management toolkit for primary lactase non-persistence — from avoidance to supplementation to tolerance strategies.
The physician gave recommendations on "what to do when she wants to eat dairy"
The key phrase in the case is that the physician provided options for when she wants to eat dairy — not simply "avoid all dairy forever." This reflects the modern management approach: total dairy avoidance is not necessary for most patients, and several evidence-based strategies allow lactose-containing foods to be tolerated. The goal is symptom control while maintaining calcium and vitamin D intake.
Strategy 1 — Exogenous lactase supplements
Lactase enzyme supplements (e.g., Lactaid) contain β-galactosidase from Aspergillus oryzae or Kluyveromyces lactis (fungal/yeast sources). Taken immediately before or with dairy-containing meals.
Mechanism: Exogenous β-galactosidase hydrolyzes lactose in the food (pre-digestion if added to milk) or in the small intestinal lumen (if taken as a pill with the meal) → glucose + galactose → absorbed normally via SGLT1. Bypasses the absent endogenous lactase entirely.
Limitations: Efficacy is dose-dependent and variable between individuals. May not completely eliminate symptoms with very large lactose loads. Does not work if forgotten or taken late. Available as drops, chewable tablets, or capsules.
Strategy 2 — Reduced-lactose and lactose-free products
Lactose-free milk is produced by adding exogenous lactase to milk and allowing pre-hydrolysis of lactose before packaging. The resulting product contains glucose and galactose (already hydrolyzed) instead of lactose — tastes slightly sweeter but is nutritionally equivalent.
Key fact: Hard aged cheeses (cheddar, parmesan, Swiss) have very low residual lactose content because the fermentation process during cheese-making converts most lactose. A patient who cannot tolerate a glass of milk may be perfectly comfortable eating aged cheese.
Yogurt with live active cultures is often better tolerated than milk because the bacterial cultures (Lactobacillus, Streptococcus thermophilus) produce their own β-galactosidase that aids lactose digestion in the gut.
Strategy 3 — Dose and context modifications
- 1Small doses with meals: Taking dairy with solid food slows gastric emptying → lactose delivered to the small intestine more slowly → residual lactase (even the tiny 2 units) has more time per unit of lactose → better tolerance than drinking milk on an empty stomach.
- 2Distribute intake: Spreading dairy intake throughout the day (small amounts with each meal) rather than one large serving allows better symptom management within residual enzyme capacity.
- 3Gradual colonic adaptation: Regular small exposures to lactose promote colonic bacterial adaptation — the bacterial community gradually shifts toward more β-galactosidase-producing bacteria that can ferment lactose more efficiently, producing less gas and fewer symptoms over weeks.
Strategy 4 — Calcium and vitamin D maintenance
This is the most medically important nutritional consideration. Dairy is the primary dietary source of calcium and vitamin D in most Western diets. Eliminating dairy without replacement creates real risk:
Risk at this patient's age (18 yo): Peak bone mass is achieved between ages 18–25. This is the critical window for building skeletal calcium stores that protect against osteoporosis decades later. Calcium restriction during this window has permanent consequences for bone density.
Alternatives the physician likely recommended: Calcium-fortified non-dairy milks (soy, almond, oat — check that they're fortified), canned salmon/sardines with bones, leafy greens (kale, bok choy — spinach contains oxalates that reduce calcium absorption), calcium supplements (calcium citrate is better absorbed than calcium carbonate, especially without food). Vitamin D supplementation separately since most non-dairy foods don't contain it.
Dairy product lactose content — not all dairy is equal
| Product | Lactose per serving | Tolerance in LNP | Reason |
|---|---|---|---|
| Whole milk (1 cup) | ~12g | Poor | High lactose, liquid → fast gastric emptying → rapid delivery to bowel |
| Ice cream (½ cup) | ~6g | Moderate | Fat slows gastric emptying somewhat |
| Yogurt with live cultures (1 cup) | ~5g (partially pre-digested) | Often well tolerated | Bacterial β-galactosidase aids digestion in GI tract |
| Cheddar cheese (1 oz) | <0.5g | Usually well tolerated | Fermentation during aging converts most lactose; low residual |
| Butter (1 tbsp) | <0.1g | Well tolerated | Primarily fat; negligible lactose content |
| Lactose-free milk | ~0g | Fully tolerated | Pre-hydrolyzed by exogenous lactase during manufacturing |
Practical bottom line: Most patients with primary lactase non-persistence can tolerate up to ~12g lactose per sitting (one cup of milk equivalent) if taken with food, and aged cheeses and yogurt with live cultures are usually well tolerated without any intervention. Total dairy avoidance is rarely necessary and carries nutritional risk.
Self-Test
10 Board-Style Questions
Cover the answers and work through each question.
Lactase is 5% of normal (2 vs. 44) while maltase (88%), sucrase (89%), and isomaltase (86%) are all essentially normal. The isolation of the deficiency to lactase alone is critical. If all enzymes were reduced, this would indicate diffuse mucosal damage (celiac, Crohn's, infection) and the biopsy would show pathology. The normal histology + selective lactase reduction = primary lactase non-persistence, not structural intestinal disease.
Unhydrolyzed lactose passes intact to the colon. Two mechanisms operate simultaneously: (1) Osmotic diarrhea — lactose is an osmotically active solute that draws water into the colonic lumen. (2) Bacterial fermentation — colonic bacteria ferment lactose to short-chain fatty acids + CO₂ + H₂ gas → bloating, cramping, gurgling (borborygmi). The H₂ produced is absorbed into blood and exhaled — detected by the hydrogen breath test. Stool becomes acidic (pH <5.5) from fermentation products.
SGLT1 (Sodium-Glucose Linked Transporter 1, SLC5A1). Secondary active transporter — cotransports 2 Na⁺ with each glucose or galactose molecule. Energy source: indirectly from ATP, consumed by basolateral Na⁺/K⁺-ATPase to maintain the low intracellular Na⁺ gradient that drives the SGLT1 cotransport. SGLT1 itself uses no ATP. Fructose uses the separate GLUT5 transporter (facilitated diffusion, no Na⁺ coupling).
GLUT2 (SLC2A2) on the basolateral membrane. Facilitated diffusion — moves monosaccharides down their concentration gradient. No energy, no Na⁺. Low affinity (high Km ~17 mM) but very high capacity — designed for large post-meal glucose surges. Transports glucose, galactose, and fructose equally. Can also be recruited to the apical membrane at very high luminal glucose concentrations as a high-capacity overflow route alongside SGLT1.
Maltase-glucoamylase: α-1,4 bonds (terminal, in maltose and oligosaccharides) → glucose. Sucrase: α-1,2 bond in sucrose → glucose + fructose. Isomaltase: α-1,6 branch point bonds in α-limit dextrins → glucose. Lactase-phlorizin hydrolase: β-1,4 bond in lactose → glucose + galactose. Trehalase: α-1,1 bond in trehalose → glucose + glucose. Key fact: lactase is the ONLY enzyme that cleaves β linkages — all others handle α-glycosidic bonds.
Gradual onset in late adolescence is characteristic of primary lactase non-persistence. The LCT gene is programmed to downregulate after weaning in ~65% of humans — this decline is gradual, typically beginning in childhood (ages 2-5) and continuing through adolescence. By the late teens, lactase activity reaches its permanently low adult level. Onset from birth = congenital deficiency (rare, autosomal recessive, coding sequence mutation). Acute onset after illness = secondary deficiency (reversible, all enzymes affected). Gradual onset in teens = primary non-persistence (permanent, selective, regulatory SNP).
Lactase persistence = continued high lactase expression into adulthood. Caused by SNPs in a regulatory enhancer region ~14 kb upstream of the LCT gene (not in the coding sequence). Key SNP: C/T-13910 in European populations. Multiple independent mutations arose in different dairying cultures (convergent evolution). Evolved ~10,000 years ago coinciding with cattle domestication. One of the strongest signals of positive selection in the human genome — adults who could digest milk had caloric advantage during famines. ~35% of humans worldwide have lactase persistence; ~65% have non-persistence. Northern Europeans: ~90% persistence. East Asians: ~10% persistence.
The hydrogen breath test is the standard non-invasive diagnostic test for lactase deficiency. Method: patient ingests a standard lactose dose (usually 25-50g); exhaled H₂ is measured at baseline and every 30 minutes for 3 hours. Mechanism: unabsorbed lactose reaches colon → colonic bacteria ferment it → produce H₂ (and CH₄) → H₂ absorbed into portal blood → excreted in lungs → detected in breath. A rise in breath H₂ >20 ppm above baseline at 2-3 hours = positive test. The test confirms both lactose malabsorption AND that symptoms correlate with the malabsorption.
Yogurt bacterial cultures (Lactobacillus delbrueckii, Streptococcus thermophilus) produce β-galactosidase themselves. When these live bacteria reach the small intestine and colon, their microbial lactase aids in digesting the remaining lactose. Additionally, the fermentation process during yogurt-making pre-hydrolyzes some of the lactose before consumption. The slower gastric emptying of yogurt (thicker consistency than milk) also provides more time for residual host lactase to act. Evidence: hydrogen breath test shows lower H₂ production after yogurt than after equivalent lactose in milk.
Calcium and vitamin D intake. Dairy is the primary dietary source of both in Western diets. Age 18 is critical because peak bone mass is achieved between ages 18-25 — this is the most important window for maximizing skeletal calcium density. Calcium restriction during this period has permanent consequences for lifetime bone density and osteoporosis risk decades later. Management: lactose-free dairy, calcium-fortified non-dairy milks, canned fish with bones, leafy greens (kale, bok choy — not spinach due to oxalate binding), calcium supplements (citrate preferred), separate vitamin D supplementation.